Results
|
|
161.
|
Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps. [electronic resource] by
- Catalán-Serra, Ignacio
- Huguet-Malavés, Jose María
- Mínguez, Miguel
- Torrella, Emilio
- Paredes, Jose María
- Vázquez, Narciso
- Ramírez, Jose Joaquín
- Calvo, Félix
- Nos, Pilar
- Gutiérrez, Ana
- Palau, Antonio
- Cortés, Javier
- Ramón-Monllor, Pilar
- Hinojosa, Joaquín
Producer: 20170317
In:
Gastroenterologia y hepatologia vol. 38
Availability: No items available.
|
|
|
162.
|
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. [electronic resource] by
- De Mattos-Arruda, Leticia
- Bottai, Giulia
- Nuciforo, Paolo G
- Di Tommaso, Luca
- Giovannetti, Elisa
- Peg, Vicente
- Losurdo, Agnese
- Pérez-Garcia, José
- Masci, Giovanna
- Corsi, Fabio
- Cortés, Javier
- Seoane, Joan
- Calin, George A
- Santarpia, Libero
Producer: 20160907
In:
Oncotarget vol. 6
Availability: No items available.
|
|
|
163.
|
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial. [electronic resource] by
- von Minckwitz, Gunter
- Puglisi, Fabio
- Cortes, Javier
- Vrdoljak, Eduard
- Marschner, Norbert
- Zielinski, Christoph
- Villanueva, Cristian
- Romieu, Gilles
- Lang, István
- Ciruelos, Eva
- De Laurentiis, Michele
- Veyret, Corinne
- de Ducla, Sabine
- Freudensprung, Ulrich
- Srock, Stefanie
- Gligorov, Joseph
Producer: 20150127
In:
The Lancet. Oncology vol. 15
Availability: No items available.
|
|
|
164.
|
HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial. [electronic resource] by
- Llombart-Cussac, Antonio
- Cortés, Javier
- Paré, Laia
- Galván, Patricia
- Bermejo, Begoña
- Martínez, Noelia
- Vidal, Maria
- Pernas, Sònia
- López, Rafael
- Muñoz, Montserrat
- Nuciforo, Paolo
- Morales, Serafín
- Oliveira, Mafalda
- de la Peña, Lorena
- Peláez, Alexandra
- Prat, Aleix
Producer: 20170608
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|
|
|
165.
|
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. [electronic resource] by
- Swain, Sandra M
- Miles, David
- Kim, Sung-Bae
- Im, Young-Hyuck
- Im, Seock-Ah
- Semiglazov, Vladimir
- Ciruelos, Eva
- Schneeweiss, Andreas
- Loi, Sherene
- Monturus, Estefanía
- Clark, Emma
- Knott, Adam
- Restuccia, Eleonora
- Benyunes, Mark C
- Cortés, Javier
Producer: 20200709
In:
The Lancet. Oncology vol. 21
Availability: No items available.
|
|
|
166.
|
First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study. [electronic resource] by
- Bergh, Jonas
- Bondarenko, Igor M
- Lichinitser, Mikhail R
- Liljegren, Annelie
- Greil, Richard
- Voytko, Nataliya L
- Makhson, Anatoly N
- Cortes, Javier
- Lortholary, Alain
- Bischoff, Joachim
- Chan, Arlene
- Delaloge, Suzette
- Huang, Xin
- Kern, Kenneth A
- Giorgetti, Carla
Producer: 20120508
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30
Availability: No items available.
|
|
|
167.
|
Change in Topoisomerase 1-Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol. [electronic resource] by
- Rugo, Hope S
- Cortes, Javier
- Awada, Ahmad
- O'Shaughnessy, Joyce
- Twelves, Chris
- Im, Seock-Ah
- Hannah, Alison
- Lu, Lin
- Sy, Sherwin
- Caygill, Katie
- Zajchowski, Deborah A
- Davis, Darren W
- Tagliaferri, Mary
- Hoch, Ute
- Perez, Edith A
Producer: 20191220
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24
Availability: No items available.
|
|
|
168.
|
Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer. [electronic resource] by
- Méndez, Olga
- Peg, Vicente
- Salvans, Cándida
- Pujals, Mireia
- Fernández, Yolanda
- Abasolo, Ibane
- Pérez, José
- Matres, Ana
- Valeri, Marta
- Gregori, Josep
- Villarreal, Laura
- Schwartz, Simó
- Ramon Y Cajal, Santiago
- Tabernero, Josep
- Cortés, Javier
- Arribas, Joaquín
- Villanueva, Josep
Producer: 20191119
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24
Availability: No items available.
|
|
|
169.
|
ERRATUM: Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity. [electronic resource] by
- Prat, Aleix
- Adamo, Barbara
- Fan, Cheng
- Peg, Vicente
- Vidal, Maria
- Galván, Patricia
- Vivancos, Ana
- Nuciforo, Paolo
- Palmer, Héctor G
- Dawood, Shaheenah
- Rodón, Jordi
- Cajal, Santiago Ramon Y
- Campo, Josep Maria Del
- Felip, Enriqueta
- Tabernero, Josep
- Cortés, Javier
Producer: 20150710
In:
Scientific reports vol. 5
Availability: No items available.
|
|
|
170.
|
High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy. [electronic resource] by
- Nuciforo, Paolo
- Thyparambil, Sheeno
- Aura, Claudia
- Garrido-Castro, Ana
- Vilaro, Marta
- Peg, Vicente
- Jimenez, José
- Vicario, Rocio
- Cecchi, Fabiola
- Hoos, William
- Burrows, Jon
- Hembrough, Todd
- Ferreres, Juan Carles
- Perez-Garcia, José
- Arribas, Joaquin
- Cortes, Javier
- Scaltriti, Maurizio
Producer: 20161019
In:
Molecular oncology vol. 10
Availability: No items available.
|
|
|
171.
|
Role of total tumour load of sentinel lymph node on survival in early breast cancer patients. [electronic resource] by
- Peg, Vicente
- Sansano, Irene
- Vieites, Begoña
- Bernet, Laia
- Cano, Rafael
- Córdoba, Alicia
- Sancho, Magdalena
- Martín, María Dolores
- Vilardell, Felip
- Cazorla, Alicia
- Espinosa-Bravo, Martín
- Pérez-García, José Manuel
- Cortés, Javier
- Rubio, Isabel T
- Ramón Y Cajal, Santiago
Producer: 20180309
In:
Breast (Edinburgh, Scotland) vol. 33
Availability: No items available.
|
|
|
172.
|
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer. [electronic resource] by
- Miles, David W
- Chan, Arlene
- Dirix, Luc Y
- Cortés, Javier
- Pivot, Xavier
- Tomczak, Piotr
- Delozier, Thierry
- Sohn, Joo Hyuk
- Provencher, Louise
- Puglisi, Fabio
- Harbeck, Nadia
- Steger, Guenther G
- Schneeweiss, Andreas
- Wardley, Andrew M
- Chlistalla, Andreas
- Romieu, Gilles
Producer: 20100720
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
|
173.
|
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel. [electronic resource] by
- Cortés, Javier
- Swain, Sandra M
- Kudaba, Iveta
- Hauschild, Maik
- Patel, Taral
- Grincuka, Elza
- Masuda, Norikazu
- McNally, Virginia
- Ross, Graham
- Brewster, Mike
- Marier, Jean-François
- Trinh, My My
- Garg, Amit
- Nijem, Ihsan
- Visich, Jennifer
- Lum, Bert L
- Baselga, José
Producer: 20140505
In:
Anti-cancer drugs vol. 24
Availability: No items available.
|
|
|
174.
|
Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer. [electronic resource] by
- Quintela-Fandino, Miguel
- Morales, Serafín
- Cortés-Salgado, Alfonso
- Manso, Luis
- Apala, Juan V
- Muñoz, Manuel
- Gasol Cudos, Ariadna
- Salla Fortuny, Joel
- Gion, María
- Lopez-Alonso, Antonio
- Cortés, Javier
- Guerra, Juan
- Malón, Diego
- Caleiras, Eduardo
- Mulero, Francisca
- Mouron, Silvana
Producer: 20201001
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26
Availability: No items available.
|
|
|
175.
|
Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2. [electronic resource] by
- Martino-Echarri, Estefanía
- Fernández-Rodríguez, Rubén
- Rodríguez-Baena, Francisco Javier
- Barrientos-Durán, Antonio
- Torres-Collado, Antoni X
- Plaza-Calonge, María del Carmen
- Amador-Cubero, Suyapa
- Cortés, Javier
- Reynolds, Louise E
- Hodivala-Dilke, Kairbaan M
- Rodríguez-Manzaneque, Juan Carlos
Producer: 20140306
In:
International journal of cancer vol. 133
Availability: No items available.
|
|
|
176.
|
Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancer. [electronic resource] by
- Cortés, Javier
- Fumoleau, Pierre
- Bianchi, Giulia Valeria
- Petrella, Teresa M
- Gelmon, Karen
- Pivot, Xavier
- Verma, Shailendra
- Albanell, Joan
- Conte, Pierfranco
- Lluch, Ana
- Salvagni, Stefania
- Servent, Veronique
- Gianni, Luca
- Scaltriti, Maurizio
- Ross, Graham A
- Dixon, Joanna
- Szado, Tania
- Baselga, José
Producer: 20120712
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30
Availability: No items available.
|
|
|
177.
|
Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy. [electronic resource] by
- Parra-Palau, Josep Lluís
- Morancho, Beatriz
- Peg, Vicente
- Escorihuela, Marta
- Scaltriti, Maurizio
- Vicario, Rocio
- Zacarias-Fluck, Mariano
- Pedersen, Kim
- Pandiella, Atanasio
- Nuciforo, Paolo
- Serra, Violeta
- Cortés, Javier
- Baselga, José
- Perou, Charles M
- Prat, Aleix
- Rubio, Isabel T
- Arribas, Joaquín
Producer: 20150126
In:
Journal of the National Cancer Institute vol. 106
Availability: No items available.
|
|
|
178.
|
Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study. [electronic resource] by
- Ortega, Vanesa
- Antón, Antonio
- Garau, Isabel
- Afonso, Noemia
- Calvo, Lourdes
- Fernández, Yolanda
- Martínez-García, María
- Blanco, Esperanza
- Zamora, Pilar
- García, Mirta
- Illarramendi, José Juan
- Rodríguez Sánchez, César Augusto
- Sampayo, Miguel
- Aguirre, Elena
- Pérez-García, José Manuel
- Cortés, Javier
- Llombart-Cussac, Antonio
Producer: 20200414
In:
Clinical breast cancer vol. 19
Availability: No items available.
|
|
|
179.
|
Enhancing global access to cancer medicines. [electronic resource] by
- Cortes, Javier
- Perez-García, Jose Manuel
- Llombart-Cussac, Antonio
- Curigliano, Giuseppe
- El Saghir, Nagi S
- Cardoso, Fatima
- Barrios, Carlos H
- Wagle, Shama
- Roman, Javier
- Harbeck, Nadia
- Eniu, Alexandru
- Kaufman, Peter A
- Tabernero, Josep
- García-Estévez, Laura
- Schmid, Peter
- Arribas, Joaquín
Producer: 20200908
In:
CA: a cancer journal for clinicians vol. 70
Availability: No items available.
|
|
|
180.
|
Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study. [electronic resource] by
- Cortes, Javier
- Di Cosimo, Serena
- Climent, Miguel A
- Cortés-Funes, Hernán
- Lluch, Ana
- Gascón, Pere
- Mayordomo, José I
- Gil, Miguel
- Benavides, Manuel
- Cirera, Lluís
- Ojeda, Belén
- Rodríguez, César A
- Trigo, José M
- Vazquez, Josep
- Regueiro, Pilar
- Dorado, Juan F
- Baselga, José
Producer: 20090507
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 15
Availability: No items available.
|